文献速递肾小球疾病

GalNAc-T14可能参与产生半乳糖缺陷型免疫球蛋白A1——IgA肾病的主要自身抗原

GalNAc-T14 may Contribute to Production of Galactose-Deficient Immunoglobulin A1, the Main Autoantigen in IgA Nephropathy.
PubMed 文献 · Kidney Int Rep · 2023-02-13

该研究分析IgA肾病患者与健康对照外周血单个核细胞中GALNT14的表达,并在Dakiki细胞中评估过表达或敲低GalNAc-T14对半乳糖缺陷型IgA1(Gd-IgA1)产生的影响。结果显示IgA肾病患者PBMCs中GALNT14过表达,IL-6可增加其表达;过表达GalNAc-T14增强IgA1半乳糖缺陷,而siRNA敲低则减少该缺陷。作者认为黏膜感染炎症信号诱导的GALNT14过表达可能促进IgA肾病患者Gd-IgA1过度产生。

要点

  • IgA肾病患者外周血单个核细胞中GALNT14过表达。
  • IL-6可增加IgA肾病患者及健康对照PBMCs中GALNT14表达。
  • Dakiki细胞中过表达GalNAc-T14增强IgA1半乳糖缺陷,敲低则减少。

核心结论

  • 黏膜感染期间炎症信号诱导的GALNT14过表达可能促进IgA肾病患者Gd-IgA1的过度产生。

研究设计与样本

  • 分析IgA肾病患者与健康对照外周血单个核细胞中GALNT14表达,并在Dakiki细胞中评估GALNT14过表达或敲低对Gd-IgA1产生的影响。

主要发现

  • GALNT14在IgA肾病患者PBMCs中过表达。
  • IL-6增加IgA肾病患者和健康对照PBMCs中GALNT14表达。
  • Dakiki细胞中过表达GalNAc-T14增强IgA1半乳糖缺陷,而siRNA介导的GalNAc-T14敲低减少该缺陷。
  • GalNAc-T14定位于反面高尔基体网络。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Immunoglobulin A1 (IgA1) with galactose-deficient O-glycans (Gd-IgA1) play a key role in the pathogenesis of IgA nephropathy (IgAN). Mucosal-tissue infections increase IL-6 production and, in patients with IgAN, are often associated with macroscopic hematuria. IgA1-secreting cell lines derived from the circulation of patients with IgAN, compared to those of healthy controls (HCs), produce more IgA1 that has O-glycans with terminal or sialylated N-acetylgalactosamine (GalNAc). GalNAc residues are added to IgA1 hinge region by some of the 20 GalNAc transferases, the O-glycosylation-initiating enzymes. Expression of GALNT2, encoding GalNAc-T2, the main enzyme initiating IgA1 O-glycosylation, is similar in cells derived from patients with IgAN and HCs. In this report, we extend our observations of GALNT14 overexpression in IgA1-producing cell lines from patients with IgAN. METHODS: GALNT14 expression was analyzed in peripheral blood mononuclear cells (PBMCs) from patients with IgAN and from HCs. Moreover, the effect of GALNT14 overexpression or knock-down on Gd-IgA1 production in Dakiki cells was assessed. RESULTS: GALNT14 was overexpressed in PBMCs from patients with IgAN. IL-6 increased GALNT14 expression in PBMCs from patients with IgAN and HCs. We used IgA1-producing cell line Dakiki, a previously reported model of Gd-IgA1-producing cells, and showed that overexpression of GalNAc-T14 enhanced galactose deficiency of IgA1, whereas siRNA-mediated GalNAc-T14 knock-down reduced it. GalNAc-T14 was localized in trans-Golgi network, as expected. CONCLUSIONS: Overexpression of GALNT14 due to inflammatory signals during mucosal infections may contribute to overproduction of Gd-IgA1 in patients with IgAN.

来源:Kidney Int Rep,查看原文。版权归原作者所有。

引用

  1. Jemelkova J, Stuchlova Horynova M, Kosztyu P, et al. GalNAc-T14 may Contribute to Production of Galactose-Deficient Immunoglobulin A1, the Main Autoantigen in IgA Nephropathy. Kidney Int Rep. 2023. PMID: 37180502. doi:10.1016/j.ekir.2023.02.1072

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。